AREC — Arecor Therapeutics Share News
0.000.00%
- £16.42m
- £13.40m
- £5.05m
RCS - Arecor Therapeutics - Arecor on Investor Meet Company Platform
AnnouncementREG - Arecor Therapeutics - Interim Results for six months ended 30 June 2023
AnnouncementREG - Arecor Therapeutics - Arecor: positive Hikma FDA pre-IND meeting
AnnouncementRCS - Arecor Therapeutics - TETRIS PHARMA ANNOUNCES AGREEMENT WITH GOODLIFE
AnnouncementREG - Arecor Therapeutics - Collaboration With Top 10 Global Pharma
AnnouncementREG - Arecor Therapeutics - Notice of Interim Results
AnnouncementREG - Arecor Therapeutics - Arecor Business Update
AnnouncementREG - Arecor Therapeutics - Additional Agreement with Leading Biopharma
AnnouncementREG - Arecor Therapeutics - Arecor granted key patents in Europe and China
AnnouncementRCS - Arecor Therapeutics - Arecor presents positive data for AT247 at ADA
AnnouncementREG - Arecor Therapeutics - Exercise of rollover options & Total Voting Rights
AnnouncementREG - Arecor Therapeutics - Result of AGM
AnnouncementREG - Arecor Therapeutics - AGM Statement
AnnouncementREG - Arecor Therapeutics - Director/PDMR Shareholding
AnnouncementRCS - Arecor Therapeutics - TETRIS PHARMA LAUNCHES OGLUO® IN DENMARK & NORWAY
AnnouncementREG - Arecor Therapeutics - ARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM
AnnouncementREG - Arecor Therapeutics - Arecor Granted Key U.S Patent
AnnouncementRCS - Arecor Therapeutics - Arecor on Investor Meet Company Platform
AnnouncementREG - Arecor Therapeutics - Unaudited Preliminary Results for 2022
Announcement